Related Experiment Videos
Helicobacter pylori and nonmalignant diseases
Ernst J Kuipers1, Peter Malfertheiner
1Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center, 3000 CA Rotterdam, the Netherlands. e.j.kuipers@erasmusmc.nl
Helicobacter
|September 7, 2004
Summary
Helicobacter pylori eradication effectively treats peptic ulcer disease but offers limited benefits for non-ulcer dyspepsia. Eradication is key for secondary ulcer prevention in NSAID users and resolves gastritis in GERD patients on PPIs.
Area of Science:
- Gastroenterology
- Microbiology
- Internal Medicine
Background:
- Helicobacter pylori (H. pylori) colonization is linked to various upper gastrointestinal diseases.
- Recent literature provides updated insights into H. pylori's role in non-malignant conditions.
Purpose of the Study:
- To review recent literature on the association between H. pylori and non-malignant upper gastrointestinal diseases.
- To evaluate the efficacy of H. pylori eradication for conditions like peptic ulcer disease, non-ulcer dyspepsia, and GERD.
Main Methods:
- Literature review of studies published within the past year.
- Analysis of data concerning H. pylori eradication outcomes in different gastrointestinal conditions.
Main Results:
- H. pylori eradication is the most effective therapy for peptic ulcer disease, though dyspeptic symptoms may persist.
- Eradication shows minimal effect on primary ulcer prevention in NSAID users but is relevant for secondary prevention.
- Limited benefits are observed for H. pylori eradication in non-ulcer dyspepsia.
- H. pylori eradication does not consistently increase GERD risk and resolves pangastritis in GERD patients on PPIs.
Conclusions:
- H. pylori eradication is crucial for peptic ulcer disease management and secondary prevention in NSAID users.
- While benefits for non-ulcer dyspepsia are limited, eradication is clinically indicated for specific conditions.
- H. pylori management in GERD patients on PPIs should continue for accepted indications, as eradication resolves gastritis without affecting PPI efficacy.